| $337M | ||
| $259M | ||
| $79M | ||
| $60M | ||
| $58M | ||
| $50M |
Buys | $ | – | |
Sells | $ | – |
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Over the last 12 months, insiders at Accolade, Inc. have bought $undefined and sold $undefined worth of Accolade, Inc. stock.
On average, over the past 5 years, insiders at Accolade, Inc. have bought $178,758 and sold $4.27M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 74 shares for transaction amount of $743 was made by Barnes Stephen H. (Chief Financial Officer) on 2022‑08‑02.
| Increased Positions | 0 | 0% | 0 | 0% |
| Decreased Positions | 0 | 0% | 0 | 0% |
| New Positions | 0 | New | 0 | New |
| Sold Out Positions | 0 | Sold Out | 0 | Sold Out |
| Total Postitions | 0 | 0% | 0 | 0% |